WSJournal. Illicit Botox Sparks

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

WSJournal. Illicit Botox Sparks Alert

http://online.wsj.com/article/SB10001424127887324731304578193990868029934.html?mod=ITP_marketplace_0

Regulators said last week they warned 350 medical practices that they may have purchased unapproved—and potentially counterfeit—versions of the drug Botox from a network of wholesalers controlled by Canada Drugs, an international supplier linked earlier this year to fake cancer medicines.

The warnings mark the fifth time the U.S. Food and Drug Administration has alerted doctors of suspect, overseas drugs this year, largely sold by Canada Drugs' companies. In February, the agency first told cancer doctors that they had bought a cornstarch and acetone-based imitation of Avastin, a Roche Holdings AG ROG.VX +0.86% medicine, from the network. More than 500 American doctors have now received warnings.

A sample of Botox

Canada Drugs, a 10-year-old Internet pharmacy based in Winnipeg, has profited for years by selling cheaper, foreign versions of medicines from price-controlled markets such as the U.K. and Turkey to American customers and doctors. But the FDA considers the activity illegal, even when the drugs are authentic medicines, because those drugs aren't approved by the agency. That business, as the Avastin episode showed, introduces the risk that fake medicine may reach American customers.

The agency sought unsuccessfully to shut down Canada Drugs' consumer-focused website in September, and is investigating the company, officials said. Canada Drugs executives didn't respond to a request for comment. Canada Drugs' employees earlier acknowledged in interviews that they shipped the fake Avastin but said they didn't know it was counterfeit.

And, in a sign a broader crackdown on illicit medicines is gaining momentum, drug makers are forging a deal with international police group Interpol to fund some law-enforcement efforts.

Administrators at two medical practices identified by the FDA as buyers of the suspect Botox said sales representatives from Quality Specialty Products, Bridgewater Medical, and other Canada Drugs-owned companies pitched doctors' offices discounted vials of the medicine.

"They said it was the same Botox that Allergan AGN -1.22% sells, but it was not made in the United States," said the practice manager of a small Illinois neurology practice who ordered Botox from Bridgewater Medical. "I was assured it was the same product, but it was just less expensive." The practice ceased ordering the product after a doctor became aware it was of foreign origin, the manager said. Allergan Inc. makes Botox.

These medical-practice employees declined to speak for attribution, saying they didn't want to draw negative attention to their employers. More than a dozen other practices declined to comment or didn't return phone messages.

Quality Specialty Products, Bridgewater Medical and other purveyors of suspect Botox identified by the FDA are either companies acquired by Canada Drugs or trade names used by its representatives, according to business documents and former Canada Drugs employees.

A series of incidents in the past year stretching beyond Canada Drugs underscored gaps in the U.S. drug-supply chain's security. Executives for at least three other drug wholesalers that allegedly sold foreign medicines in the U.S. have been charged with crimes in recent months.

A Tennessee oncologist pleaded guilty last month to a felony count of buying an unapproved cancer drug with the intent to defraud the state's Medicaid program and other health-care purchasers. The oncologist, William Kincaid of Johnson City, Tenn., could face up to three years in prison.

Drug makers and law-enforcement officials have been working for several years to crack down on counterfeit and foreign, misbranded medicines. Since February, Congress has sharpened penalties for selling fake drugs. And pharmaceutical-industry executives have pushed hard to accelerate the efforts.

"The Avastin case has put some wind behind some sails here on enforcement," said Bruce Longbottom, an Eli Lilly LLY +0.61% & Co. trademark lawyer focused on drug diversion and counterfeiting.

As part of the industry's growing enforcement efforts, Merck MRK -1.52% & Co. "began hiring former officers of U.S. and foreign intelligence services, such as the Central Intelligence Agency, building greater capabilities to address the international counterfeit threat to patient safety," said Grant Ashley, security chief for the Whitehouse Station, N.J., drug maker.

In the Interpol deal, a group of 27 drug companies would finance some of the police organization's efforts to crack down on illicit medicine sales, drug-firm security officials and law-enforcement officers say. In the unusual arrangement, Interpol would use the industry money to pay for training for local law enforcement and efforts to track cases in which culprits operate in several nations.

That deal is expected to be completed early next year, officials said. "This is an innovative solution in addressing a global crime problem, and one which most importantly will significantly contribute to protecting the health and safety of people throughout the world," Interpol spokeswoman Rachael Billington said.

In the latest cases, the FDA said it hadn't confirmed whether any patients had received the suspect versions of Botox. It said the products were unapproved, meaning they weren't manufactured at FDA-inspected facilities and packaged for U.S. sale. "If the FDA confirms any counterfeit products, we will notify the public," said spokeswoman Sarah Clark-Lynn.

A spokeswoman for Allergan said the company learned of the suspect Botox vials from the FDA last week. In a statement, the company said, "[w]e cannot confirm the safety or authenticity of products that are imported from unauthorized distributors."

Botox, or Botulinum toxin, is known for its cosmetic use, in which doctors inject it into muscles to relax frown lines and wrinkles. About half of the product, though, is sold for therapeutic uses, including treatment of migraines and urinary incontinence, the company said. Allergan sells genuine Botox to doctors for $525 per vial.

Fake and foreign Botox has appeared before in U.S. medical practices, court records show. In 2006, Chad Livdahl, owner of an Arizona distributor, was sentenced to nine years in prison for crimes related to the marketing of unapproved versions of Botox that the FDA said temporarily paralyzed some patients.

Mr. Livdahl, who was released early in 2009, didn't respond to requests for comment through his attorney. The attorney, Maria Elena Perez, said he maintained "his Botox never harmed anyone."

Write to Christopher Weaver at christopher.weaver@wsj.com

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fire-Resistant Lubricants Offer a Quiet Value Shift

Updated Category News Views 60

Hydraulic fluid is not the sort of product that gets anyone pounding the table, and that is precisely why this little industrial pocket deserves a hard look. The fire-resistant lubricants market is estimated at $2.35 billion in 2026 and projected to reach $2.83 billion by 2031, implying a 3.74% compound annual growth rate. That is not a rocket ship. It is a slow-moving,...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 54

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 167

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
Lieda Shadwick’s Career Education Work Earns 2026 Honor

Updated Category News Views 101

Twenty-six years in classrooms is not the sort of accomplishment that needs fireworks to carry weight. Lieda A. Shadwick’s recognition as The Inner Circle’s 2026 Educator of the Year points to a career built around a stubbornly important idea: students need more than academic vocabulary if they are going to navigate work, leadership, and business with any confidence....

Continue Reading
Liquidity Services Faces a Brutal Revenue Reality Check

Updated Category News Views 59

A 19.17% opening haircut is the market ringing the fire alarm, not politely clearing its throat. Liquidity Services reported fiscal fourth-quarter revenue of $106.4 million, roughly 10% below the prior-year quarter, and shareholders got hit hard on November 19, 2026. That reaction is ugly, but it is not mysterious. When a company built around moving surplus inventory...

Continue Reading
Everyday Dose Tests Coffee in a New Pocket Format Today

Updated Category News Views 66

Coffee has finally wandered into the candy aisle, and I cannot decide whether that is clever or mildly exhausting. Everyday Dose and Austin-based Le Lick have launched Le Latte, a limited-batch coffee-flavored electrolyte lollipop aimed at adults who want caffeine without hauling around a cup. It is an odd little product, sure, but odd is often where consumer brands find...

Continue Reading
FFR Adds Academic and Commercial Muscle to Its Board

Updated Category News Views 65

Robotics boards can get crowded with lofty nouns fast, and FFR just added another one with some real-world connective tissue behind it. Carolyn Kissane, associate dean at NYU's Center for Global Affairs, has joined as an independent director. The appointment is not a product launch, a contract, or revenue. It is a governance move. Still, in a business trying to weld...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 196

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 76

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 56

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading

Top 5 Most Recently Viewed Articles

Exyte's New Leadership: Katrien Verlinden Takes Charge

Updated Category News Views 262

Exyte Appoints Katrien Verlinden as President of ATF Exyte is excited to announce the appointment of Katrien Verlinden as the new President of its Global Business Unit (GBU) Advanced Technology Facilities (ATF). This significant change is set to take effect soon, marking a pivotal moment for the company. Leadership Experience and Vision Katrien Verlinden brings over 25...

Continue Reading
Webull's Exciting New Deposit Bonus Sparks Retail Trading Surge

Updated Category News Views 241

Webull Set to Captivate Retail Investors with Innovative Offers Retail investors have been making a notable comeback in U.S. markets, engaging at levels almost unmatched since the meme-stock frenzy of 2021. This renewed enthusiasm has sparked a competitive race among trading platforms eager to seize this opportunity. Webull stands out with its timely initiative,...

Continue Reading
SMCP Reports Strong Q1 2025 Performance with Organic Growth

Updated Category News Views 245

SMCP Reports Solid Growth in Q1 2025 SMCP has announced a remarkable increase in its sales for the first quarter of 2025, demonstrating robust growth across numerous key markets. With total sales reaching €297 million, this marks a 2.6% hike on an organic basis compared to the previous year's performance, where sales were at €287 million. This growth can be attributed...

Continue Reading
Ambow Education Reports Strong Financial Results for 2025

Updated Category News Views 157

Ambow Education Delivers Impressive Results for 2025 Ambow Education Holding Ltd. (AMBO), a leader in AI-driven hybrid education solutions, has made headlines with a recent release that highlights its robust financial performance in 2025. The company reported significant growth and achievements that mark a transformative period for its operations. Unveiling Financial...

Continue Reading
Fundy Designer Expands Design Library for Photographers

Updated Category News Views 177

Fundy Designer Unveils New Templates for Photographers As the busy fall sales season approaches, Fundy Designer has upgraded its Design Library, now boasting over $10,000 in templates for its subscribers. This update brings a fresh assortment of holiday cards and senior graduation album templates, designed to meet the varied needs of professional photographers. A Diverse...

Continue Reading